Emerging as a promising development in the battle against obesity, Retatrutide is capturing considerable attention . This treatment combines effects of two established GLP-1 receptor agonists, liraglutide, with an unique glucose-dependent hormonal component. Preliminary clinical findings have shown significant fat decrease in patients with a high B